Vital Signs - Next-Generation Sequencing Services Market: An Expanding Role in Clinical Applications Opens New Markets
Vital Signs - Next-Generation Sequencing Services Market: An Expanding Role in Clinical Applications Opens New Markets
RELEASE DATE
30-Mar-2012
30-Mar-2012
REGION
North America
North America
Research Code: 9561-00-DB-00-00
SKU: HC00645-NA-MR_04118
$1,500.00
In stock
SKU
HC00645-NA-MR_04118
Description
This issue of Vital Signs, released on March 30, 2012, provides a strategic insight on the next-generation sequencing services market.
Additionally, a company spotlight is provided for Foundation Medicine. Founded in 2010, the cancer diagnostics firm aims to transform cancer care by including comprehensive molecular analysis of tumors from next-generation sequencing to the diagnostic process. Reimbursement and regulatory news from the FDA is also provided for week of March 12, 2012.
Table of Contents
This week's issue
Related Research
This issue of Vital Signs, released on March 30, 2012, provides a strategic insight on the next-generation sequencing services market. Additionally, a company spotlight is provided for Foundation Medicine. Founded in 2010, the cancer diagnostics firm aims to transform cancer care by including comprehensive molecular analysis of tumors from next-generation sequencing to the diagnostic process. Reimbursement and regulatory news from the FDA is also provided for week of March 12, 2012.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-DB-00-00 |
Is Prebook | No |